Improving Radiotherapy Responses in Head and Neck Cancer With Galectin-1
1 Views
administrator
07/06/23
Dhanya K. Nambiar, PhD, Stanford University, discusses a study exploring galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers.
-
Category
Show more
Facebook Comments
No comments found